Breath Diagnostics, Inc. Investors

Breath Diagnostics, Inc. was incorporated in 2001 with a focus in developing a new quality in cellular imaging, specifically targeted at automated cancer diagnostics. The team and leadership have considerable prior-company experience in the creation of cutting-edge technology and its stewardship through product development and manufacturing to market introduction, including FDA 510(k) and Class III PMA processes, foreign regulatory approvals, and the reimbursement process as required in the in vitro diagnostics (IVD) marketplace.

Contact Us

If you are interested in learning more about Breath Diagnostics, Inc. and would like to speak with someone, please complete the short inquiry form and a Breath Diagnostics representative will contact you as soon as possible.